News

Novo Nordisk’s Wegovy debuts in India: How it works, who it’s for, and how much it costs
Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...
Anti-obesity mkt heats up as Mounjaro's Kwikpen version gets India approval
Eli Lilly receives approval for Mounjaro in prefilled Kwikpen as competition intensifies in India's weight-loss drug market ...
Wegovy: The price, perks, and pitfalls of India’s new weight-loss craze
Wegovy, the ₹26K/month weight-loss jab, hits India with bold promises—from fat loss to heart health. But is this pharma fix a ...
Novo Nordisk follows smart pricing for Wegovy in India; easy to use, says top local executive
We wanted to price it in India in a way which is comparable to the therapies that are available,' said Vikrant Shrotriya, ...
Novo Nordisk's $50 Obesity Shot Hits India -- The Drug War Just Got Real
Novo Nordisk is making a strategic move into one of the world's fastest-growing obesity markets by launching its blockbuster ...
Novo Nordisk launches weight-loss drug Wegovy in India to compete with rival Lilly's Mounjaro
By Rishika Sadam and Kashish Tandon HYDERABAD (Reuters) -Danish drugmaker Novo Nordisk launched its blockbuster weight-loss ...